Assembly Historical Income Statement
| ASMB Stock | USD 13.86 0.60 4.15% |
Historical analysis of Assembly Biosciences income statement accounts such as Interest Expense of 544.1 K, Selling General Administrative of 17.7 M or Other Operating Expenses of 61 M can show how well Assembly Biosciences performed in making a profits. Evaluating Assembly Biosciences income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Assembly Biosciences's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Assembly Biosciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Assembly Biosciences is a good buy for the upcoming year.
Assembly |
About Assembly Income Statement Analysis
Assembly Biosciences Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Assembly Biosciences shareholders. The income statement also shows Assembly investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Assembly Biosciences Income Statement Chart
Add Fundamental
Interest Expense
The cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Assembly Biosciences. It is also known as Assembly Biosciences overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Net Income Applicable To Common Shares
The net income that remains after preferred dividends have been deducted, available to common shareholders.Most accounts from Assembly Biosciences' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Assembly Biosciences current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Assembly Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. For information on how to trade Assembly Stock refer to our How to Trade Assembly Stock guide.At present, Assembly Biosciences' Depreciation And Amortization is projected to increase significantly based on the last few years of reporting. The current year's Income Tax Expense is expected to grow to about 39.8 K, whereas Interest Expense is forecasted to decline to about 544.1 K.
| 2022 | 2023 | 2024 | 2025 (projected) | Interest Income | 1.0M | 2.4M | 2.2M | 1.6M | Net Interest Income | 1.0M | 2.4M | 2.2M | 1.6M |
Assembly Biosciences income statement Correlations
Click cells to compare fundamentals
Assembly Biosciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Assembly Biosciences income statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Depreciation And Amortization | 691K | 466K | 498K | 450K | 517.5K | 543.4K | |
| Interest Expense | 4.8M | 2.6M | 82.5M | 498K | 572.7K | 544.1K | |
| Selling General Administrative | 37.1M | 28.8M | 24.1M | 22.9M | 26.3M | 17.7M | |
| Other Operating Expenses | 143.9M | 97.3M | 94.1M | 71.8M | 82.6M | 61.0M | |
| Operating Income | (64.8M) | (132.7M) | (94.1M) | (64.6M) | (58.2M) | (61.1M) | |
| Ebit | (65.5M) | (92.4M) | (94.1M) | (64.6M) | (58.2M) | (61.1M) | |
| Research Development | 106.8M | 68.5M | 70.0M | 48.9M | 56.2M | 43.3M | |
| Ebitda | (64.8M) | (91.9M) | (93.6M) | (64.2M) | (57.8M) | (60.7M) | |
| Total Operating Expenses | 143.9M | 97.3M | 94.1M | 71.8M | 82.6M | 61.0M | |
| Net Income | (59.5M) | (129.9M) | (92.1M) | (61.2M) | (55.1M) | (57.9M) | |
| Income Tax Expense | (2.6M) | (2.5M) | (1.0M) | 33K | 38.0K | 39.8K | |
| Income Before Tax | (62.2M) | (132.4M) | (93.1M) | (61.2M) | (70.4M) | (73.9M) | |
| Total Other Income Expense Net | 2.6M | 302K | 1.0M | 3.5M | 4.0M | 4.2M | |
| Total Revenue | 16.0M | 79.1M | 6.3M | 7.2M | 8.2M | 11.2M | |
| Gross Profit | 79.0M | 5.8M | (498K) | (41.7M) | (48.0M) | (45.6M) | |
| Net Income From Continuing Ops | (62.2M) | (129.9M) | (93.1M) | (72.7M) | (65.4M) | (68.7M) | |
| Cost Of Revenue | 101.3K | 466K | 498K | 48.9M | 56.2M | 59.0M | |
| Non Operating Income Net Other | 3.1M | 4.3M | 2.6M | 1.0M | 1.2M | 1.3M | |
| Net Income Applicable To Common Shares | (97.6M) | (62.2M) | (129.9M) | (93.1M) | (83.8M) | (88.0M) | |
| Tax Provision | (741K) | (2.5M) | 0.0 | 33K | 38.0K | 39.8K | |
| Net Interest Income | 2.6M | 302K | 1.0M | 2.4M | 2.2M | 1.6M | |
| Interest Income | 2.6M | 302K | 1.0M | 2.4M | 2.2M | 1.6M | |
| Reconciled Depreciation | 691K | 466K | 498K | 490K | 563.5K | 550.2K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Assembly Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Assembly Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Assembly Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Assembly Biosciences Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Assembly Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. For information on how to trade Assembly Stock refer to our How to Trade Assembly Stock guide.You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Assembly Biosciences. If investors know Assembly will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Assembly Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (6.89) | Revenue Per Share | Quarterly Revenue Growth (1.00) | Return On Assets | Return On Equity |
The market value of Assembly Biosciences is measured differently than its book value, which is the value of Assembly that is recorded on the company's balance sheet. Investors also form their own opinion of Assembly Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Assembly Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Assembly Biosciences' market value can be influenced by many factors that don't directly affect Assembly Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Assembly Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Assembly Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Assembly Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.